A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients Geographic Atrophy (GA) - FILLY

Administered By

Awarded By

Contributors

Start/End

  • August 1, 2015 - May 31, 2019